Assessing the Impact of an Sexually Transmitted Infections Nurse on the Delivery of Sexually Transmitted Infections/Human Immunodeficiency Virus Services in an Inner-City Emergency Department Using a Human Immunodeficiency Virus/Syphilis Point-of-Care Test During a Syphilis Outbreak in Alberta, Canada Authors: Jennifer Gratrix, Noel Ives, Cari Egan, Carla Vetland, Garret Meyer, Shannon Harrington, Rob Wittmeier, Alkarim Velji, Byron Berenger, Sean Rourke, Kevin Fonseca, Ameeta E. Singh Published: 2026 ABSTRACT Background:A sexually transmitted infection (STI) nurse was embedded in an emergency department (ED) to support implementation of human immunodeficiency virus (HIV) and syphilis point-of-care testing (POCT).Methods:Outcomes were compared between two time periods: (1) routine care and (2) the introduction of HIV/syphilis treponemal POCT and an STI nurse. POCT and standard serology were offered to eligible people with HIV or syphilis as a differential diagnosis, who were at risk of loss to follow-up, or who were pregnant without prenatal screening. Testing volumes, rates of new diagnoses, and treatment initiation between the time periods were compared using Chi-square or Fisher exact tests for categorical variables and Mann–Whitney U test for continuous variables.Results:A total of 2689 visits included HIV or syphilis testing, with serology more common in the postintervention period than in the preintervention period (HIV: 91.0% vs 81.4%, P < 0.001; syphilis: 86.4% vs 77.8%, P < 0.001). Rates of newly diagnosed syphilis increased slightly in the postintervention period (0.12% vs 0.09%; P = 0.07), with more same-visit syphilis treatment initiated in the postintervention period (54.1% vs 17.6%, P < 0.001). The number of newly diagnosed syphilis cases was 46.7% higher in STI registered nurse (RN) visits (n = 44) than ED Staff-only (n = 30), all new cases of HIV were found during STI RN visits, and POCT was ordered in 78.4% (n = 472) of the STI RN visits as compared with 15.6% (n = 178) of visits with ED staff-only (P < 0.001).Conclusions:An STI nurse in an urban ED contributed to the increased HIV and syphilis testing rates, and same-visit syphilis treatment initiation. Syphilis, a sexually transmitted infection (STI), when untreated, can lead to serious complications, including vertical transmission to the fetus (congenital syphilis, CS), leading to significant complications including stillbirth.1 Syphilis has been around for centuries but in recent years, rates have been increasing across Canada. In 2022, Canada reported nearly 14,000 cases of infectious (primary, secondary, and early latent) syphilis, a 109% increase since 2018.2 Approximately one-third of cases were reported among women, with the highest rates seen in the Prairie Provinces (including Alberta) and adjacent territories. In 2022, there were 117 cases of confirmed CS reported in Canada, a 6-fold increase since 2018.2 Alberta also reported a dramatic rise in CS cases, with 20% of congenital cases resulting in stillbirth.3 The expected number of CS cases is zero due to publicly funded healthcare, which includes national guidelines for universal syphilis screening as part of routine prenatal care.4 CS is preventable with early diagnosis and treatment. In addition, the national rate of human immunodeficiency virus (HIV) (6.1 per 100,00 population) in 2023 rose from a low (3.5 per 100,000) in 2020.5 Rates of syphilis co-infection in Canada ranging from 8% to 56% depending on the population studied.6 Most syphilis cases in Alberta reported opposite sex partners, and many cases have occurred among people who self-reported as Indigenous, experiencing houselessness, or residing in rural or remote communities.7–9 Some of the reasons for the reported increase in cases included the intersecting epidemic of stimulant drug use, together with the impact of racism and colonization, unstable housing, poverty, incarceration, and other social determinants of health which may lead to stigma and mistrust of the healthcare system and decreased utilization of health services.8 In Alberta, nearly all pregnant women with syphilis had some healthcare contact, mostly in acute care, but only 39% were screened for syphilis in their first trimester.10 Treatment later in pregnancy was associated with infants being diagnosed with CS.10 In a smaller review by Alberta Health (unpublished data), it was found that nearly one-half of pregnant people had a touchpoint with an emergency department (ED) while pregnant. Multiple studies have demonstrated the importance of the ED in providing opportunistic screening for syphilis and other communicable diseases.11,12 The role of point-of-care testing (POCT) for syphilis and HIV has been evaluated in several settings including EDs, correctional facilities and community settings in Alberta.13,14 POCT provides the opportunity for screening and if positive, same-visit treatment for syphilis and linkage to specialty care for HIV. The Alberta studies identified newly diagnosed cases of syphilis and HIV with high same-visit treatment rates for syphilis (85%–93%) and linkages to care for HIV. Previous studies have explored barriers to HIV screening in EDs and have identified provider discomfort about disclosing results, time constraints, result follow-up and a desire to focus on the primary presenting complaint.15–18 To address these concerns, in response to the Edmonton area having the highest rates in the provincial syphilis outbreak, a public health STI registered nurse (RN) was embedded in an inner-city ED to triage, assess, and recommend patients for syphilis and HIV screening including the use of POCT with standard serology to facilitate same-visit treatment. We aimed to evaluate the impact of introducing POCT on syphilis/HIV testing rates, same-visit treatment/linkage to care and to measure the contributions of the STI RN. MATERIALS AND METHODS We conducted a retrospective pre- and postintervention study comparing ED visits with STI testing through routine care (preintervention) versus the addition of POCT with an STI RN (postintervention). Data from patients ≥16 y of age receiving syphilis or HIV testing at an inner-city ED in Edmonton (population 1.2 million) was extracted between October 1, 2022 and September 30, 2024, from the provincial electronic medical record (EMR) on March 12, 2025.19 This intervention study was conducted at the Royal Alexandra Hospital (RAH) which has 908 beds and handles approximately 84,000 ED visits annually serving the inner city of Edmonton.20 Recent data reported that approximately 14% of visits were discharged within 4 h and 27% were admitted within 8 h.21 Nearly ten percent (8.7%) of infectious syphilis cases and two-thirds (64.4%; n = 74) of infants with CS in Edmonton were diagnosed at the RAH between 2018 and 2021 (unpublished data). During both the pre- and postintervention period, standard testing for HIV was conducted using a fourth-generation HIV Antigen/antibody Combo enzyme immunoassays (EIA; Abbott Laboratories, IL). Confirmation of a reactive screening test was completed using the Geenius HIV-1/2 Antibody Differentiation Assay. Standard testing for syphilis was completed following a reverse screening algorithm, beginning with an EIA and, if reactive, followed by a quantitative rapid plasma reagin (RPR) and a Treponema pallidum particle agglutination assay (TPPA), if not previously confirmed in Alberta. For all patients with confirmed syphilis serology, new infections were staged and treated according to provincial government guidelines.22 Patients were offered same-visit treatment based on clinical presentation (chancre, rash) or being a contact to syphilis. The preintervention period was from October 1, 2022 to September 30, 2023; syphilis and HIV testing were ordered by the attending physicians using standard serology where follow-up of positive results generally occurred in the community. The postintervention period was from October 1, 2023 to September 30, 2024; and consisted of two parts: (1) active identification of patients for testing by an STI RN and (2) introduction of POCT in conjunction with standard serology. A dedicated RN, from the public health funded STI Clinic, attended the ED on weekdays from 0700 to 1515h (23% of ED hours) to triage people who met the following inclusion criteria: (1) 16 to 65 y of age, (2) at risk of being lost to follow-up (houseless, from a rural or remote community, or in correctional custody), (3) pregnant people who had no prenatal screening, (4) people with presenting complaints associated with substance use, and (5) recent STI in the past year. For people with a recent STI, records were reviewed in the provincial communicable disease database to identify outstanding STI treatment or follow-up needs. The STI RN recommended and obtained patient consent for STI testing (standard and/or POCT) and treatment for the attending physicians to place the orders for patients who had not been screened in the previous 3 months, unless outstanding STI care needs were identified. The STI RN provided patient education and completed public health reporting and partner interviews. When POCT (INSTI Multiplex HIV-1/HIV-2/Syphilis Antibody [bioLytical Laboratories Inc., Richmond, Canada]) was recommended, it was done according to the manufacturer instructions using venous blood and in conjunction with standard serology for HIV and syphilis. The POCT was conducted in the hospital laboratory, using serum, with results provided to the ordering provider within less than an hour. The on-site laboratory was chosen to conduct the POCT to enable a single blood draw from the patient for standard syphilis/HIV testing, other ED lab orders, and the POCT. For those with reactive syphilis POC test results and no previous history of syphilis, same-visit treatment was offered. The bioLytical POC test is unable to distinguish between new and previous infections; therefore, patients with previously reactive syphilis results were not offered same-visit treatment. Patients with positive confirmatory HIV serology were connected to an HIV program for treatment. For patients with HIV reactive POC test results, posttest counseling was provided to include the possibility of false positive results, while awaiting confirmatory serology results. The total number of ED visits with syphilis or HIV testing was extracted and anonymized before analysis. Variables included client demographics, previous history of syphilis and HIV, visit diagnosis, STI testing and results, ordering provider, and any syphilis treatment provided. The proportion of ED visits was calculated as the number of individuals with syphilis or HIV testing divided by the total number of visits for the study period. The rate of newly diagnosed cases was calculated by dividing the number of new cases by the total number of ED visits and multiplied by 100. A comparison of pre- and postintervention periods, and those with an STI RN visit to those with ED staff-only in the postintervention period, was completed using Chi-square or Fisher exact tests for categorical variables and Mann–Whitney U test for continuous variables. Comparisons were considered statistically significant if the P value was <0.05. Due to the small number of pregnant participants, analysis was limited to testing outcomes. Positive percent agreement (sensitivity) and negative percent agreement (specificity) were calculated for each infection as a percentage with an associated 95% confidence interval (95% CI) comparing POC test results to standard serology. Excluded from the calculations were visits with an invalid POC test result (n = 1) or serology results that were EIA reactive and TPPA negative or indeterminate (n = 4). Statistical analysis was performed using SPSS version 29.0.2.0. The University of Alberta Health Research Ethics Board (Pro 00143891) approved the study. Verbal consent was obtained for testing which was conducted as part of routine clinical care. RESULTS Between October 1, 2022 and September 30, 2024, there were 120,375 ED visits in patients 16 y of age or older, and 2.2% (n = 2689) of these visits involved testing for HIV and/or syphilis with a greater proportion (2.8%; 1745/62,106) of testing occurring in the postintervention period compared with the preintervention period (1.6%; 944/58,269; P ≤ 0.001). For patients with visits including syphilis and/or HIV testing, over one-half (55.9%; n = 1502) were among women, 32.9% (n = 884) had a diagnosis related to substance use, one-quarter (25.1%; n = 674) were experiencing houselessness, and 4.1% (n = 109) were pregnant (Table 1). TABLE 1.Demographics, Diagnostic Characteristics, and Testing Outcomes by Intervention Period (October 2022 to September 2024, Royal Alexandra Hospital, Edmonton, Alberta)Pre (n = 944)Post (n = 1745)Total (N = 2869)P ValueDemographicsn (%)n (%)n (%) Sex Men383 (40.6)796 (45.6)1179 (43.8)0.011* Women561 (59.4)941 (53.9)1502 (55.9) Other-8 (0.5)8 (0.3) Median age (IQR)33 (26–41)34 (27–42)33 (26–42)0.042 Pregnant40 (4.2)69 (4.0)109 (4.1)0.722 Houseless209 (22.1)465 (26.6)674 (25.1)0.01 In correctional custody46 (4.9)87 (5.0)133 (4.9)0.898Medical history History of HIV23 (2.4)34 (1.9)57 (2.1)0.402 History of syphilis172 (18.2)346 (19.8)518 (19.3)0.313Diagnoses at visit Symptoms/exposure to STI282 (29.9)383 (21.3)665 (24.7)<0.001 Substance use274 (29.0)610 (35.0)884 (32.9)0.002 Sexual assault85 (9.0)85 (4.9)170 (6.3)<0.001STI testing HIV serology768 (81.4)1587 (90.9)2355 (87.6)<0.001 New diagnosis of HIV5 (0.7)3 (0.2)8 (0.3)0.123 Syphilis Serology734 (77.8)1506 (86.3)2240 (83.3)<0.001 New diagnosis of syphilis50 (6.8)74 (4.9)124 (5.5)0.065 Syphilis treatment initiation at ED8 (16.0)40 (54.1)48 (38.7)<0.001 Chlamydia and Gonorrhea Testing512 (54.2)906 (51.9)1418 (52.7)0.251 Chlamydia positive results60 (11.7)95 (10.5)155 (10.9)0.475 Gonorrhea positive results71 (13.9)104 (11.5)175 (12.3)0.189*P value calculated between male and female patients due to small cell size of other sex.ED, emergency department; HIV, human immunodeficiency virus; IQR, interquartile range; STI, sexually transmitted infections. Demographics, Diagnostic Characteristics, and Testing Outcomes by Intervention Period (October 2022 to September 2024, Royal Alexandra Hospital, Edmonton, Alberta) P value calculated between male and female patients due to small cell size of other sex. ED, emergency department; HIV, human immunodeficiency virus; IQR, interquartile range; STI, sexually transmitted infections. Nearly two-thirds (64.9%; n = 1745) of the visits with STI/HIV testing occurred in the postintervention period. During the postintervention period, patients were more likely to be unhoused and have a diagnosis of substance use as compared with the preintervention period. Patients were more likely to have syphilis serology (77.8% vs 86.3%; P < 0.001) and treatment initiated (16.0% vs 54.1%; P < 0.001) in the ED during the postintervention period (Table 1). The rate of newly diagnosed syphilis cases among all ED attendees was higher in the postintervention period (0.12%; 74/62,106) than in the preintervention period (0.09%; 50/58,269; P = 0.07), representing a 48% increase in newly diagnosed cases. The rate (0.01%) of newly diagnosed HIV cases was similar in both time periods (Fig. 1). No new cases of syphilis or HIV were identified among pregnant people. Outcomes of syphilis and HIV testing by intervention period. During the postintervention period, syphilis POCT results were available for 37.2% (n = 649) visits and 6.0% (n = 39) were reactive (Fig. 2). The syphilis component had a sensitivity of 78.7% (37/47; 95% CI = 65.1%–88.0%) and specificity of 99·7% (592/594; 95% CI = 98.8%–99.9%) when compared with all EIA+ and TPPA+ results, regardless of RPR results. Positive POC test results had a 100% agreement when the RPR dilution was ≥1:4 dilutions (n = 31). POCT identified nearly one-half (48.6%; 36/74) of the newly diagnosed cases of syphilis and 91.7% (n = 33) had treatment initiated at the same visit compared with 18.4% (n = 6) of newly diagnosed cases using serology alone (P ≤ 0.001). Ten of the infectious syphilis cases were among women of child-bearing age (20–44 y) with 80% (n = 8) treated at the same visit. The HIV component of the POC test had a sensitivity of 100·0% (3/3; 95% CI = 43.9%–100.0%) and specificity of 99·2% (636/641; 95% CI = 98.2%–99.7%), contributing to the new diagnosis of one person with HIV. Five of the eight positive POC test results were confirmed as negative with serology (Fig. 2). Syphilis/HIV point-of-care testing serology and treatment outcomes. To determine the contribution of the STI RN to the increase in syphilis and HIV care during the postintervention period, a comparison of syphilis/HIV testing visits with STI RN involvement versus ED staff-only was completed (Table 2). STI RN testing visits were more likely to include patients who were unhoused, in correctional custody, and have a diagnosis of substance use. STI RN visits had a higher proportion of patients with syphilis, HIV, chlamydia and gonorrhea testing, newly diagnosed syphilis cases, and initiation of treatment in the ED, than visits by ED staff-only. The number of newly diagnosed syphilis cases was 46.7% higher in STI RN visits (n = 44) than ED Staff-only (n = 30). During the postintervention period, all new cases of HIV were found during STI RN visits (Table 2). POCT was ordered in 78.4% (n = 472) of the STI RN visits as compared with 15.6% (n = 178) of visits with ED staff-only (P < 0.001). TABLE 2.Demographics, Diagnostic Characteristics, and Testing Outcomes in the Postintervention Period by STI RN Involvement (October 2023 to September 2024, Royal Alexandra Hospital, Edmonton, Alberta)STI RN Involvement (n = 602)ED Staff-Only (n = 1143)Total (N = 1745)P ValueDemographicsn (%)n (%)n (%) Sex<0.001* Men331 (55.0)465 (40.7)796 (45.6) Women267 (44.4)674 (59.0)941 (53.9) Other4 (0.7)4 (0.3)8 (0.5) Median age (IQR)35 (28–43)33 (26–42)34 (27–42)0.042 Pregnant14 (2.3)55 (4.8)69 (4.0)0.011 Houseless202 (33.6)263 (23.0)465 (26.6)<0.001 In correctional custody44 (7.3)43 (3.8)87 (5.0)0.001Medical history History of HIV1 (0.2)33 (2.9)34 (1.9)<0.001 History of syphilis126 (20.9)220 (19.2)346 (19.8)0.402Diagnoses at visit Symptoms/exposure to STI62 (10.3)321 (28.1)383 (21.9)<0.001 Substance use277 (46.0)333 (29.1)610 (35.0)<0.001 Sexual assault7 (1.2)78 (6.8)85 (4.9)<0.001STI testing HIV serology592 (98.3)995 (87.1)1587 (90.9)<0.001 New diagnosis of HIV3 (0.5)-3 (0.2)0.052 Syphilis serology595 (98.8)911 (79.7)1506 (86.3)<0.001 New diagnosis of syphilis44 (7.4)30 (3.3)74 (4.9)<0.001 Syphilis treatment initiation at ED28 (63.6)12 (40.0)40 (54.1)0.045 Chlamydia and gonorrhea testing336 (55.8)570 (49.9)906 (51.9)0.018 Chlamydia positive results33 (9.8)62 (10.9)95 (10.5)0.616 Gonorrhea positive results32 (9.5)72 (12.6)104 (11.5)0.156*P value calculated between male and female patients due to small cell size of other sex.ED, emergency department; HIV, human immunodeficiency virus; IQR, interquartile range; STI, sexually transmitted infections. Demographics, Diagnostic Characteristics, and Testing Outcomes in the Postintervention Period by STI RN Involvement (October 2023 to September 2024, Royal Alexandra Hospital, Edmonton, Alberta) P value calculated between male and female patients due to small cell size of other sex. ED, emergency department; HIV, human immunodeficiency virus; IQR, interquartile range; STI, sexually transmitted infections. DISCUSSION This is the first Canadian study examining the outcomes of introducing the newly Health Canada-approved syphilis/HIV POC test supported by an embedded public health STI RN in an urban inner-city hospital ED during a syphilis outbreak. The ED is an important safety net for underserved populations at risk for STBBI, making it an important setting to deliver services to patients with barriers to accessing primary care.23 The placement of the STI RN in the ED led to nearly doubled testing rates for syphilis and HIV and an increase in newly diagnosed syphilis cases and same-visit treatment initiation. A variety of other approaches have been used to increase opportunistic screening and linkages to care for communicable diseases through the ED.12 One of the ways is to utilize EMRs to generate alerts that remind ED physicians to screen for syphilis when a pregnant person or people at risk for syphilis (e.g., people who use substances, those experiencing incarceration) present for care in the ED. However, a trial of an EMR alert in our region was largely unsuccessful due to the ability to override the alert to screen pregnant women and incorrect classification of pregnancy at the time of the visit. Our model used a targeted approach to syphilis and HIV screening due to limited test kits and human resources at a single site. The low number of pregnant patients included in the study is likely a result of triaging patients presenting to the ED with a known pregnancy ≥20 wk gestation with a pregnancy-related concern to obstetrical units. Ensuring accurate assessment of pregnancy status in the ED could enable the provision of early screening and treatment (if needed) to newly pregnant people. Additional cases may have been detected if all patients presenting to the ED were screened but the cost-effectiveness of this approach would need to be assessed.11,24,25 A recent systematic literature review of the cost-effectiveness of syphilis screening in pregnant women found that cost-effectiveness increased when using dual tests (syphilis and HIV) and when POCT integrated treatment.26 The STI RN utilized the POC test significantly more than ED physicians. This could be related to their dedicated role in following up on results and the comfort they feel responding to positive syphilis and HIV results. Ideally, testing and treatment decisions should be made before discharge from the ED. Linking persons with positive syphilis tests and experiencing barriers to care such as houselessness to treatment can be challenging. The STI RN was able to facilitate this and to follow-up on people who had been tested by ED staff when the STI RN was not present. Other studies have examined other models of providing immediate access to specialized consultation or to multidisciplinary teams to provide advice and facilitate treatment.27 The use of health navigators in the ED has also been proposed to overcome implementation barriers, as ED physicians may be reluctant to support opportunistic screening due to competing priorities in this high acuity environment and lack of reimbursement for screening.12 ED physicians have also been reticent to offer STI testing due to the additional time and resources required to locate and arrange treatment of people when standard laboratory testing returns positive results in individuals who been discharged from the ED. The STI RN served multiple functions in the ED, including acting as an ED-based health navigator. They worked alongside clinical staff, offered pre- and posttest counseling, conducted clinical assessments, and preordered testing for approval by the ED physician. Additionally, they provided treatment if indicated, completed public health reporting, and interviewed for partners. As a member of the public health team, the STI RN had unique access to the provincial STI database, which included all people testing positive for a notifiable STI. This allowed them to identify patients who had been lost to care or identified as contacts. The ability to opportunistically find and treat these cases is especially useful for people experiencing houselessness, who do not have a primary care provider, and cannot be contacted using traditional methods. The STI RN was able to transfer care of patients requiring further testing or treatment in the community to the public health STI partner notification nurses who ensure that all cases and contacts are located, and linked to testing and treatment as needed.16 Finally, the STI RN was also able to provide STI education and support to ED providers and patients. The contribution of the STI RN was demonstrated by the comprehensive STI care provided with minimal hours in the ED, leading to an increase in the number of newly diagnosed syphilis cases and treatment initiation in the ED. Nearly all visits with the STI RN resulted in both syphilis and HIV testing being completed. It is worth noting that the STI RN was more likely than physicians to screen individuals who might not typically be tested for STIs and HIV in the ED, such as those who were asymptomatic and did not have a diagnosis of sexual assault. Although physicians screened symptomatic people for STIs, prior studies have reported that as few as 3% to 4% of patients tested for STIs were concurrently tested for syphilis and HIV.28,29 In addition, the high chlamydia and gonorrhea positivity rates (10.5% and 11.5%, respectively) support the strategy of offering testing for multiple STIs at the same time as testing for syphilis and HIV. While these successes are noteworthy, we anticipate that further successes of the STI RN role would have been achieved if the RN had been permitted to screen and/or treat individuals in the ER without the need for a co-signature on the EMR orders by an ED physician. This could be overcome through the development of nursing protocols for STI screening, which have been implemented in our provincial correctional facilities. The day shift was chosen for the STI RN to facilitate referrals to community providers, provide a consistent resource for ED staff through their shift rotations, and limited funding. Additional hours or adjusting the shift times of the STI RN may have increased uptake or reached different populations. Another enhancement to POCT uptake is the utilization of the POC test at the bedside. Bedside POCT performed by an STI RN at another center was initiated to address concerns about prolonging ED stay times while awaiting the results of lab based POCT. Since the introduction of this option, RNs report more engagement from patients when treatment is needed. Another challenge to testing is that ED patients had to be in a care space, not in a waiting room, to be screened or treated. In 2022, in Alberta, approximately 8.7% of patients left the ED without being seen with an even higher proportion (21.2% year-to-date 2025) at the RAH.30,31s The ability to offer prompt screening in the waiting room may have facilitated additional testing. After consulting with our hospital ethicist, we determined that individuals with altered levels of consciousness could not be tested without consent, thereby limiting screening opportunities. In addition, using POC tests that can distinguish between new syphilis infections and past infections would be beneficial as outbreaks progress. More data are needed to confirm the ability of dual syphilis (treponemal and non-treponemal) POCT to distinguish between previous and active syphilis infections.32s Our findings may not be generalizable to other settings since our study was conducted during a period of high syphilis resurgence and low prior syphilis positivity in our region, primarily affecting individuals experiencing houselessness and substance use. We anticipate that rates of newly diagnosed cases would be lower in areas with lower syphilis prevalence and affecting different subpopulations. Finally, the scope of this study did not examine the differences between people eligible for POCT who received testing and those who did not. Anecdotally, several people were excluded from testing if they were unable to provide consent for testing, for example, altered states of consciousness and/or impairment due to substance use. Using our study design, it is difficult to determine the contribution of the STI nurse versus the POCT. We chose to compare time periods in a single location, as the population served (inner-city) would be similar compared with other locations (suburban). Providers at the RAH have been caring for patients with syphilis since the inception of the outbreak in 2018, limiting the need for new provider education and awareness of the outbreak from the intervention. Since the end of the STI RN position, POCT continues to be used at the RAH, but in decreased volumes (129 tests in the year post-STI RN, unpublished data). Future studies could examine conditions related to sustainability and cost-effectiveness. In conclusion, our study employed a novel approach to enhance opportunistic screening for syphilis and HIV by integrating an STI nurse into a bustling inner-city urban ED. We observed an increase in syphilis and HIV testing. Moreover, syphilis/HIV POCT proved effective in diagnosing and treating syphilis during a single visit, and it also facilitated linking individuals with HIV to care. Future research should focus on the impact of including STI RNs in EDs in other locations with varying community-level syphilis prevalence, as well as the cost-effectiveness of this model of care.